Kewaunee Scientific Co. (NASDAQ:KEQU) Director Donald F. Shaw acquired 2,000 shares of the firm’s stock in a transaction on Wednesday, December 27th. The stock was bought at an average price of $28.79 per share, for a total transaction of $57,580.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Kewaunee Scientific Co. (NASDAQ KEQU) traded up $0.40 during trading hours on Friday, hitting $28.50. 1,800 shares of the company’s stock traded hands, compared to its average volume of 2,900. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.58 and a current ratio of 2.12. Kewaunee Scientific Co. has a 12-month low of $20.95 and a 12-month high of $31.20. The firm has a market capitalization of $76.45, a P/E ratio of 17.07 and a beta of 0.07.
Kewaunee Scientific (NASDAQ:KEQU) last posted its quarterly earnings data on Tuesday, December 5th. The technology company reported $0.62 earnings per share for the quarter. Kewaunee Scientific had a net margin of 3.28% and a return on equity of 10.61%. The business had revenue of $41.47 million during the quarter.
Several institutional investors have recently added to or reduced their stakes in the company. California Public Employees Retirement System acquired a new stake in Kewaunee Scientific during the 2nd quarter valued at approximately $202,000. Hancock Holding Co. acquired a new stake in shares of Kewaunee Scientific during the 2nd quarter worth approximately $203,000. Northern Trust Corp lifted its holdings in shares of Kewaunee Scientific by 2.3% in the 2nd quarter. Northern Trust Corp now owns 56,131 shares of the technology company’s stock worth $1,397,000 after purchasing an additional 1,284 shares in the last quarter. Finally, Vanguard Group Inc. lifted its holdings in shares of Kewaunee Scientific by 38.0% in the 2nd quarter. Vanguard Group Inc. now owns 59,560 shares of the technology company’s stock worth $1,486,000 after purchasing an additional 16,400 shares in the last quarter. 36.54% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY NOTICE: “Kewaunee Scientific Co. (KEQU) Director Donald F. Shaw Buys 2,000 Shares” was published by American Banking News and is owned by of American Banking News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/01/05/kewaunee-scientific-co-kequ-director-donald-f-shaw-buys-2000-shares.html.
Kewaunee Scientific Company Profile
Kewaunee Scientific Corporation is engaged in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel, wood and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services.
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.